Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Investing Activities (2023 - 2026)

Rallybio's Cash from Investing Activities history spans 3 years, with the latest figure at $3.9 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 349.52% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.3 million, a 41.13% increase, with the full-year FY2025 number at $47.3 million, up 41.13% from a year prior.
  • Cash from Investing Activities hit $3.9 million in Q4 2025 for Rallybio, down from $29.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for RLYB hit a ceiling of $29.2 million in Q3 2025 and a floor of -$1.6 million in Q4 2024.
  • Historically, Cash from Investing Activities has averaged $9.0 million across 3 years, with a median of $5.1 million in 2023.
  • The widest YoY moves for Cash from Investing Activities: up 623.29% in 2024, down 109.3% in 2024.
  • Tracing RLYB's Cash from Investing Activities over 3 years: stood at $16.9 million in 2023, then crashed by 109.3% to -$1.6 million in 2024, then surged by 349.52% to $3.9 million in 2025.
  • Business Quant data shows Cash from Investing Activities for RLYB at $3.9 million in Q4 2025, $29.2 million in Q3 2025, and $3.0 million in Q2 2025.